Discover investment opportunities in Adag Stocks using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Adag Stocks using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Adag Stocks using our Smart AI Filter.
7 stocks found for "Adag Stocks"
Security name | Expected returns | Sharpe Ratio | Beta | Volatility | P/E Ratio | Dividend Yield |
|---|---|---|---|---|---|---|
0.30 Risk measure | ±26.0% Price volatility | 12.1 Valuation | 0.66% Annual yield | |||
0.67 Risk measure | ±23.5% Price volatility | 9.8 Valuation | 18.34% Annual yield | |||
0.60 Risk measure | ±27.2% Price volatility | 15.6 Valuation | 3.47% Annual yield | |||
0.45 Risk measure | ±20.5% Price volatility | 12.7 Valuation | 3.02% Annual yield | |||
0.34 Risk measure | ±25.2% Price volatility | 8.0 Valuation | 0.00% Annual yield | |||
0.59 Risk measure | ±31.6% Price volatility | 34.5 Valuation | 0.77% Annual yield | |||
0.83 Risk measure | ±70.5% Price volatility | -3.5 Valuation | 0.00% Annual yield |
This search uses our Smart AI Filter to identify stocks matching your criteria. Results are ranked by relevance and include key financial metrics to help you make informed investment decisions.
Get personalized stock recommendations, save custom screens, and access premium filters. All our screening tools are free—signing up gives you more personalized results and the ability to save your research.
Compliance disclosure:
The securities listed on this website have not paid to be included in the results. The inclusion of any securities in the results shown does not imply any relationship with PortfolioPilot. The order of the results is ranked based on the Sharpe Ratio, which is a measure of risk-adjusted return. Please note that these listings are not recommendations or financial advice. Past performance is not indicative of future results.
Q: What growth potential does Adagio Therapeutics (ADAG) offer compared to larger biotech firms like Vertex (VRTX) and Biogen (BIIB)?
A: Adagio Therapeutics (ADAG) focuses on developing antibody therapies which could see growth if pipeline drugs are successful. It remains riskier compared to established firms like Vertex and Biogen, which have more diverse and approved products.
Q: How does Johnson & Johnson (JNJ) provide stability amidst biotech volatility?
A: Johnson & Johnson (JNJ) offers stability given its diversified business model spanning consumer health, pharmaceuticals, and medical devices, reducing reliance solely on biotech sector performance.
Q: What makes Eli Lilly (LLY) an attractive dividend stock?
A: Eli Lilly (LLY) has a history of consistent dividend payments, appealing to income-focused investors. Its stable pharmaceutical sales support ongoing income potential.
Q: Are there ESG factors to consider when investing in Moderna (MRNA)?
A: Moderna (MRNA) may appeal to ESG-conscious investors due to its focus on genetic medicine, which can promote public health. However, industry-specific ethical concerns should be assessed.
Q: Is Sarepta Therapeutics (SRPT) vulnerable to economic downturns?
A: Sarepta Therapeutics (SRPT) operates in a niche segment focusing on rare diseases, which may insulate it from broader economic pressures, although it remains dependent on clinical and regulatory milestones.
Q: What role does innovation play in Regeneron's (REGN) competitive advantage?
A: Regeneron's (REGN) robust pipeline and investment in innovative therapies, particularly in oncology and ophthalmology, enhance its competitive position in the biotech sector.
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
Read more